In an animal model of AD, GCA treatment reversed Aβ deposition and disruption of synaptic plasticity due to AD and protected hippocampal neuronal cells from neurotoxic damage, in addition to being associated with inhibition of AChE and BChE activity (Lee et al., 2011; Pavlikova, 2023). Here, ACHE is linked to Alzheimer disease.